l   Qisda maintains growth momentum in high value-added Businesses in Q3

l   Three Major AI Technologies to Be Showcased at Healthcare+ Expo Taiwan

Qisda (TWSE: 2352) announced its fiscal 2025 third-quarter financial results, reporting continued growth in its high value-added businesses and plans to showcase its AI capabilities at Healthcare+ Expo Taiwan this December. The BSG, Medical, and NCG businesses all achieving double-digit year-over-year growth. Among them, the Medical business will lead 20 group companies to participate in Healthcare+ Expo Taiwan on December 4, where it will showcase three major AI healthcare innovations, further expanding the group’s smart healthcare ecosystem.

Qisda held an online investor conference on November 12 to share its Q3 performance and Q4 outlook.

Qisda's Chairman, Peter Chen, stated that the company’s high value-added businesses continued to deliver steady performance in the third quarter, reflecting the results of its long-term strategic focus. Looking ahead, Qisda will continue to deepen its AI deployment, strengthen technology integration and innovation, and drive business transformation and long-term growth.

Qisda's President, Joe Huang, noted that to drive long-term growth, the group has increased AI investments across its BSG, Medical, and NCG businesses, deepening technology and product innovation to reinforce momentum in its high value-added operations. The Medical business will lead 20 group companies to participate in Healthcare+ Expo Taiwan, demonstrating AI-driven innovations and practical applications in clinical diagnostics and health management.

In terms of performance in each business group in Q3, the IT business recorded a 6% year-over-year decline in revenue, with both operating margin and operating income lower than the same period last year. The Medical business posted 15% YoY revenue growth, the BSG business grew 21% YoY, and the NCG business increased 18% YoY, with all three segments reporting modest increases in operating income compared with the prior year.

Qisda 2025 Q3 Financial Highlights

Consolidated Revenue: NT$52.532 billion, up 3% YoY and down 2% QoQ

Gross Profit: NT$8.875 billion, up 4% YoY and up 3% QoQ

Gross Margin: 16.9%, up 0.1 percentage points YoY and up 0.8 percentage points QoQ

Operating Income: NT$818 million, down 34% YoY and up 7% QoQ

Operating Income Margin: 1.6%, down 0.9 percentage points YoY and up 0.2 percentage points QoQ

Net Income: NT$385 million, down 68% YoY and up 4% QoQ

Net Income Attributable to Qisda: NT$251 million, down 76% YoY and down 29% QoQ

Earnings Per Share (EPS): NT$0.15

Qisda 2025 First Three Quarters Financial Highlights

Revenue: NT$155.7 billion, up 6% YoY
Gross Profit: NT$26.124 billion, up 7% YoY
Gross Margin: 16.8%, up 0.3 percentage points YoY
Operating Income: NT$2.579 billion, down 23% YoY
Operating Income Margin: 1.7%, down 0.6 percentage points YoY
Net Income: NT$1.349 billion, down 44% YoY
Net Income Attributable to Qisda : NT$1.09 billion, down 45% YoY
Earnings Per Share (EPS): NT$0.59